RecallRadar

FDA Drug recall D-0473-2026

Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis La…

On 2026-04-15 the FDA classified a Class II recall of Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis La… by Teva Pharmaceuticals Usa, citing CGMP Deviations: use of an unapproved raw material.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0473-2026
ClassificationClass II
Statusongoing
Initiated2026-03-19
Published2026-04-15
Last updated2026-09-13 11:52 UTC
CompanyTeva Pharmaceuticals Usa
Distributionn/a

Product

Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3509-04 carton, NDC 0591-3509-54 pouch

Reason

CGMP Deviations: use of an unapproved raw material

Identifiers

ndc0591-3508-54
ndc0591-3508-04
ndc0591-3509-54
ndc0591-3509-04
ndc0591-3510-54
ndc0591-3510-04
code_infoLot: 100060002, Exp.: 07/2026; 100066802, Exp.: 05/2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0473-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.